Anthony E. Lang,Andrew Siderowf,Eric A. Macklin,Werner Poewe,David J. Brooks,Hubert H. Fernandez,Olivier Rascol,Nir Giladi,Fabrizio Stocchi,Caroline M. Tanner,Ronald B. Postuma,David K. Simon,Eduardo Tolosa,Brit Mollenhauer,Jesse M. Cedarbaum,Kyle Fraser,James Xiao,Karleyton C. Evans,Danielle Graham,Inbal Sapir
In participants with early Parkinson's disease, the effects of cinpanemab on clinical measures of disease progression and changes in DaT-SPECT imaging did not differ from those of placebo over a 52-week period. (Funded by Biogen; SPARK ClinicalTrials.gov number, NCT03318523.).
PDF的下载单位、IP信息已删除
浮游
无极微光
GingerF
yznfly
Zx_1993
pluto
嘿嘿
昏睡的蟠桃
小青椒
Frank
风吹麦田
wxyshare
ccc2
ccm
iNk
dew
avalanche
xxfsx
liao
kentonchow
Tourist
你嵙这个期刊没买
hackfeng
nancylan
皖公网安备34019202002308
